Click for best price
Chest Cancer Molecular Diagnostics Market Size, Share 2023
A molecular approach for men to diagnose chest cancer
This report aims to provide a comprehensive presentation of the global market for Chest Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chest Cancer Molecular Diagnostics. This report contains market size and forecasts of Chest Cancer Molecular Diagnostics in global, including the following market information:
Global Chest Cancer Molecular Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Chest Cancer Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Chest Cancer Molecular Diagnostics include Roche, Qiagen, Illumina, Abbott, Oncotypeiq, BD, Tellgen, Genetech and Gpmedical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Chest Cancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chest Cancer Molecular Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Chest Cancer Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
PCR
FISH
DNA Sequencing
Gene Chip
Global Chest Cancer Molecular Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Chest Cancer Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Clinical Diagnosis
Drug Screening
Research
Global Chest Cancer Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Chest Cancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chest Cancer Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Chest Cancer Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Qiagen
Illumina
Abbott
Oncotypeiq
BD
Tellgen
Genetech
Gpmedical
Zeesan
Sansure
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chest Cancer Molecular Diagnostics, market overview.
Chapter 2: Global Chest Cancer Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Chest Cancer Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chest Cancer Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Chest Cancer Molecular Diagnostics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chest Cancer Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chest Cancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chest Cancer Molecular Diagnostics Overall Market Size
2.1 Global Chest Cancer Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Chest Cancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chest Cancer Molecular Diagnostics Players in Global Market
3.2 Top Global Chest Cancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Chest Cancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Chest Cancer Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Chest Cancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chest Cancer Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Chest Cancer Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Chest Cancer Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Chest Cancer Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Chest Cancer Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Chest Cancer Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Chest Cancer Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chest Cancer Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Chest Cancer Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Chest Cancer Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Chest Cancer Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Chest Cancer Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Chest Cancer Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Chest Cancer Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Chest Cancer Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Chest Cancer Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Chest Cancer Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Chest Cancer Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Chest Cancer Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chest Cancer Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Chest Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Chest Cancer Molecular Diagnostics Market Size, 2018-2030
7 Chest Cancer Molecular Diagnostics Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Chest Cancer Molecular Diagnostics Major Product Offerings
7.1.4 Roche Chest Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Qiagen
7.2.1 Qiagen Company Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Chest Cancer Molecular Diagnostics Major Product Offerings
7.2.4 Qiagen Chest Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Qiagen Key News & Latest Developments
7.3 Illumina
7.3.1 Illumina Company Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Chest Cancer Molecular Diagnostics Major Product Offerings
7.3.4 Illumina Chest Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Illumina Key News & Latest Developments
7.4 Abbott
7.4.1 Abbott Company Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Chest Cancer Molecular Diagnostics Major Product Offerings
7.4.4 Abbott Chest Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Abbott Key News & Latest Developments
7.5 Oncotypeiq
7.5.1 Oncotypeiq Company Summary
7.5.2 Oncotypeiq Business Overview
7.5.3 Oncotypeiq Chest Cancer Molecular Diagnostics Major Product Offerings
7.5.4 Oncotypeiq Chest Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Oncotypeiq Key News & Latest Developments
7.6 BD
7.6.1 BD Company Summary
7.6.2 BD Business Overview
7.6.3 BD Chest Cancer Molecular Diagnostics Major Product Offerings
7.6.4 BD Chest Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 BD Key News & Latest Developments
7.7 Tellgen
7.7.1 Tellgen Company Summary
7.7.2 Tellgen Business Overview
7.7.3 Tellgen Chest Cancer Molecular Diagnostics Major Product Offerings
7.7.4 Tellgen Chest Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Tellgen Key News & Latest Developments
7.8 Genetech
7.8.1 Genetech Company Summary
7.8.2 Genetech Business Overview
7.8.3 Genetech Chest Cancer Molecular Diagnostics Major Product Offerings
7.8.4 Genetech Chest Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Genetech Key News & Latest Developments
7.9 Gpmedical
7.9.1 Gpmedical Company Summary
7.9.2 Gpmedical Business Overview
7.9.3 Gpmedical Chest Cancer Molecular Diagnostics Major Product Offerings
7.9.4 Gpmedical Chest Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Gpmedical Key News & Latest Developments
7.10 Zeesan
7.10.1 Zeesan Company Summary
7.10.2 Zeesan Business Overview
7.10.3 Zeesan Chest Cancer Molecular Diagnostics Major Product Offerings
7.10.4 Zeesan Chest Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Zeesan Key News & Latest Developments
7.11 Sansure
7.11.1 Sansure Company Summary
7.11.2 Sansure Business Overview
7.11.3 Sansure Chest Cancer Molecular Diagnostics Major Product Offerings
7.11.4 Sansure Chest Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Sansure Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Chest Cancer Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Chest Cancer Molecular Diagnostics Market Drivers in Global Market
Table 3. Chest Cancer Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Chest Cancer Molecular Diagnostics in Global Market
Table 5. Top Chest Cancer Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Chest Cancer Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Chest Cancer Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Chest Cancer Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Chest Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chest Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Chest Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Chest Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Chest Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Chest Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Chest Cancer Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Chest Cancer Molecular Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Roche Company Summary
Table 31. Roche Chest Cancer Molecular Diagnostics Product Offerings
Table 32. Roche Chest Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Qiagen Company Summary
Table 35. Qiagen Chest Cancer Molecular Diagnostics Product Offerings
Table 36. Qiagen Chest Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Qiagen Key News & Latest Developments
Table 38. Illumina Company Summary
Table 39. Illumina Chest Cancer Molecular Diagnostics Product Offerings
Table 40. Illumina Chest Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Illumina Key News & Latest Developments
Table 42. Abbott Company Summary
Table 43. Abbott Chest Cancer Molecular Diagnostics Product Offerings
Table 44. Abbott Chest Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Abbott Key News & Latest Developments
Table 46. Oncotypeiq Company Summary
Table 47. Oncotypeiq Chest Cancer Molecular Diagnostics Product Offerings
Table 48. Oncotypeiq Chest Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Oncotypeiq Key News & Latest Developments
Table 50. BD Company Summary
Table 51. BD Chest Cancer Molecular Diagnostics Product Offerings
Table 52. BD Chest Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. BD Key News & Latest Developments
Table 54. Tellgen Company Summary
Table 55. Tellgen Chest Cancer Molecular Diagnostics Product Offerings
Table 56. Tellgen Chest Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Tellgen Key News & Latest Developments
Table 58. Genetech Company Summary
Table 59. Genetech Chest Cancer Molecular Diagnostics Product Offerings
Table 60. Genetech Chest Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Genetech Key News & Latest Developments
Table 62. Gpmedical Company Summary
Table 63. Gpmedical Chest Cancer Molecular Diagnostics Product Offerings
Table 64. Gpmedical Chest Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Gpmedical Key News & Latest Developments
Table 66. Zeesan Company Summary
Table 67. Zeesan Chest Cancer Molecular Diagnostics Product Offerings
Table 68. Zeesan Chest Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Zeesan Key News & Latest Developments
Table 70. Sansure Company Summary
Table 71. Sansure Chest Cancer Molecular Diagnostics Product Offerings
Table 72. Sansure Chest Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. Sansure Key News & Latest Developments
List of Figures
Figure 1. Chest Cancer Molecular Diagnostics Segment by Type in 2022
Figure 2. Chest Cancer Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Chest Cancer Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Chest Cancer Molecular Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Chest Cancer Molecular Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chest Cancer Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Chest Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Chest Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Chest Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Chest Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Chest Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Chest Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Chest Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Roche Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Qiagen Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Illumina Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Abbott Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Oncotypeiq Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. BD Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Tellgen Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Genetech Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Gpmedical Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Zeesan Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sansure Chest Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
